Esketamine Treatment in White Plains, NY: What Westchester Residents Should Know About Spravato®

Most people who end up researching Spravato® have already been through a lot. Multiple antidepressants. Dose adjustments. Medication switches. Months of waiting to see if this one might be different. By the time esketamine enters the conversation, the question isn't usually "should I try something new?" — it's "is this actually going to be different, and is it available somewhere I can realistically get to?"

For Westchester County residents, the answer to the second question is yes. Aurora Wellness offers Spravato® treatment at our White Plains location, making it one of the more accessible certified esketamine sites in the region — without requiring a trip into Manhattan.

Here's what you should understand before starting that conversation.

What Spravato® Is and Why It Works Differently

Spravato® is the FDA-approved nasal spray formulation of esketamine, a derivative of ketamine. It was approved in 2019 for two specific indications: treatment-resistant depression (TRD) — defined as major depressive disorder that hasn't responded to at least two adequate antidepressant trials — and major depressive disorder with acute suicidal ideation or behavior.

The reason it matters for people who haven't responded to standard antidepressants is the mechanism. SSRIs and SNRIs primarily work on serotonin and norepinephrine. Spravato® works on the glutamate system, targeting NMDA receptors and triggering rapid improvements in synaptic plasticity — the brain's ability to form and strengthen neural connections. This is why it can produce results in people for whom the serotonergic pathway simply hasn't been effective.

The onset is also different. Some patients notice changes within days of their first session. That's not the case for everyone, and expectations should be calibrated in conversation with a psychiatrist — but the speed of potential response is meaningfully faster than anything in the oral antidepressant category.

Who It's Actually For

Spravato® is not a first-line treatment. It's specifically designed for a population that has already worked through the standard options without adequate relief. Clinically, that generally means:

• A confirmed diagnosis of major depressive disorder

• At least two antidepressant trials at appropriate doses and durations that didn't produce sufficient improvement

• A comprehensive psychiatric evaluation confirming there are no medical or psychiatric contraindications

Contraindications include a history of psychosis, certain cardiovascular conditions, and active substance use disorder, among others. The evaluation process is thorough for this reason — Spravato® is a powerful treatment, and appropriate candidate selection matters.

What Treatment Looks Like in White Plains

Every Spravato® session takes place in our office. The medication can't be taken at home — it's self-administered under direct clinical supervision, followed by a mandatory two-hour monitoring period while staff monitors blood pressure, dissociation, and any other effects.

You'll need someone to drive you home or arrange alternative transportation. That's a practical reality worth planning around from the start.

The treatment schedule follows a structured protocol. The induction phase runs twice weekly for four weeks, followed by weekly sessions, then maintenance every one to two weeks depending on how you respond. Spravato® is used alongside an oral antidepressant — not as a standalone replacement for other psychiatric care.

Insurance and the Prior Authorization Process

Spravato® is covered by most major insurance plans when treatment-resistant depression criteria are met. The prior authorization process requires documentation that you've had at least two adequate antidepressant trials, which means working with a practice that knows how to pull that documentation together clearly.

An incomplete or poorly organized prior auth request is one of the most common reasons for initial denial. If a practice is experienced with Spravato®, they've navigated this process many times and can manage it on your behalf.

Aurora Wellness has experience working with Spravato® prior authorizations across multiple insurance plans and understands the documentation typically required for approval. Our team helps coordinate the process from evaluation through submission, including gathering treatment history, prior medication trials, and supporting clinical documentation when needed. Because prior authorization requirements can be complex and time-sensitive, having a practice familiar with the process can help reduce delays and avoid common administrative issues.

Finding the Right Provider in Westchester

Not every psychiatric practice in Westchester offers Spravato®. It requires REMS certification, appropriate clinical infrastructure, and a team that knows how to manage the evaluation, the prior authorization, and the ongoing care that follows. Certification alone doesn't tell you much about the quality of the clinical experience.

What matters is whether the practice conducts a genuine evaluation — not a checklist — and whether there's real psychiatric oversight throughout the treatment course, not just during the sessions themselves.

At Aurora Wellness, our White Plains team includes board-certified psychiatrists, PMHNPs, PA-Cs, and licensed therapists working together within the same practice. Spravato® treatment is offered in-person at our White Plains location, fully integrated with medication management and therapy. Telehealth psychiatric care is also available throughout New York State for ongoing support between sessions.

If you've been managing depression that hasn't responded adequately to standard treatment, a Spravato® evaluation in White Plains is a reasonable and accessible next step.